Press Releases

BIO Announces Richard Lobb as Managing Director of the Council for Biotechnology Information

Lobb will lead CBI’s efforts to communicate science-based information about the benefits and safety of agricultural biotechnology and its contributions to sustainable development.

BIO Hails Senate Passage of PAHPA Reauthorization

The reauthorization of the Pandemic All-Hazards Preparedness Act and the Special Reserve Fund signify the solid commitment of government attention and funding which will allow the biotech industry to do even more to help protect our nation.

BIO Praises House Passage of the Jumpstart Our Business Startups Act

House passes H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act.

BIO Announces Additional Plenary Speakers for the 2012 World Congress to Address Advanced Biofuels, Renewable Chemicals and Creation of a Biobased Economy

We are excited to offer this information-packed plenary program at the 2012 World Congress where speakers will highlight how industrial biotechnology leads to innovation and new jobs while helping to build a biobased economy.

2012 BIO International Convention Super Sessions Focus on Industry Outlook

Global Event for biotechnology to be held June 18-21, 2012 in Boston, MA.

BIO Applauds House Committee Vote to Repeal IPAB

BIO applauded the House Energy and Commerce Committee’s passage of the Medicare Decisions Accountability Act, H.R. 452, which would repeal the Independent Payment Advisory Board (IPAB) established in the health care reform law.

FAST Act Would Provide Patients with Accelerated Access to Innovative Therapies

The FAST Act will modernize the Accelerated Approval pathway to expedite the development of modern, targeted, and personalized therapies for patients suffering from serious and life-threatening diseases, while preserving the Food and Drug Administration's (FDA) robust standards for safety and effectiveness.

Biotech Leader Provides Testimony at Congressional Hearing on ‘Spurring Job Growth through Capital Formation While Protecting Investors’

OncoMed Pharmaceuticals SVP/CFO provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs

BIO Applauds Senator Stabenow’s Proposed Legislation Supporting Creation of a Biobased Economy

New "Grow It Here, Make It Here" legislation introduced today by Sen. Debbie Stabenow (D-Mich.) would help bio-based manufacturers access vital capital, strengthen market opportunities for biobased products, and spur commercialization of agricultural and industrial biotech innovations.

BIO Announces Expansion of Alliance Development Activities

The Biotechnology Industry Organization (BIO) announced today that it has integrated its alliance development activities into one department as a means of expanding engagement opportunities with external groups that share a commitment to unleashing biotechnology’s capability to benefit patients and consumers.

Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions

Member companies of three leading advanced and cellulosic biofuel trade organizations sent a letter to House and Senate leaders asking for extension of the Cellulosic Biofuels Production Tax Credit, which expires December 31, 2012.

Commercialization of Advanced Biofuels to be Key Theme at BIO World Congress on Industrial Biotechnology and Bioprocessing

Continued commercialization of the industrial biotechnology sector can drive the creation of a biobased economy, which can strengthen the nation’s economic security and enhance energy security.

BIO Applauds Strengthening of the USDA BioPreferred Program

BIO welcomes a White House memo to federal agencies that expands and strengthen the USDA BioPreferred program.

BIO Applauds Sen. Stabenow’s Grow It Here, Make It Here Initiative

BIO thanks Sen. Debbie Stabenow (D-Mich.) for announcing policy proposals in Detroit that will spur commercialization of new agricultural innovations, increase access to capital and create a new tax cut for biobased manufacturers.

BIO Asks EPA to Reject Retroactive Changes to Renewable Fuel Standard

BIO submitted a letter to EPA asking that they reject a retroactive reduction of the 2011 Renewable Fuel Standard obligations, requested in January by petroleum refiners.

BIO Plenary Speakers for the 2012 World Congress on Industrial Biotechnology and Bioprocessing to Address Advanced Biofuels, Renewable Chemicals and Creation of a Biobased Economy

Company executives, scientists and government officials will bring a global perspective as featured presenters at BIO’s 9th annual World Congress on Biotechnology and Bioprocessing.

TREAT Act Offers Renewed Hope for Patients

Feb 15 2012

The bill will modernize the FDA and accelerate patient access to cures and new treatments.

BIO Industry Analysis Investor Survey: FDA Approvals Expected to Increase and Majority of Investors Believe Now is a Good Time to Invest in Biotech

Survey data released at 14thAnnual BIO CEO & Investor Conference in New York City.

Administration‘s 2013 Budget Could Discourage Development of Cures and Breakthrough Medicines, Limit Patient Choice And Forestall Job Growth

“The biotechnology industry has long been an engine for economic development and job creation across the country and our sector is working to add more high-wage high-skilled jobs to our workforce."

BIO’s 9th Annual World Congress on Industrial Biotechnology and Bioprocessing in Orlando to Feature Presentations on Advanced Biofuels and Renewable Chemicals

“We are excited to bring this conference to Orlando to highlight the industry's growth, the importance of this industrial and environmental biotechnology for generating green jobs, making greener products and cleaner processes all aimed at building a biobased economy."

Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO

BIO President and CEO Jim Greenwood issued the following statement regarding the newly released U.S. Food and Drug Administration (FDA) guidance for the review and approval of biosimilars.

More Farmers Favor Biotech Crops

Because of their tremendous environmental and economic benefits, farmers around the world continue to adopt genetically engineered (GE) crops according to a report released today by the International Service for the Acquisition of Agri-Biotech Applications (ISAAA).

BIO Testifies on Importance of Prompt Enactment of PDUFA V Recommendations

Feb 1 2012

In the testimony, Richard Pops, Alkermes plc Chairman and CEO, stressed the need for a quick reauthorization of the Prescription Drug User Fee Act (PDUFA) and enactment of the enhancements recommended in the PDUFA V agreement.

14th Annual BIO CEO & Investor Conference to Highlight 2012 Investment Outlook, New Business Models and Key Therapeutic Topics

Jan 31 2012

The Biotechnology Industry Organization (BIO) announces plenary sessions, Business Roundtables and Therapeutic Workshops selected for the 14th Annual BIO CEO & Investor Conference.

BIO Congratulates ZeaChem, Applauds USDA Loan Guarantee Announcement

The USDA's loan guarantee program is helping advanced biofuel companies attract necessary financing for commercial projects. Projects like ZeaChem's can bring jobs and economic growth to rural areas.